# Comparison of Anti-Ischemic Drug Therapy and Percutaneous Transluminal Angioplasty After Myocardial Infarction

> **NCT00387231** · NA · COMPLETED · sponsor: **Luzerner Kantonsspital**

## Conditions studied

- Myocardial Ischemia

## Interventions

- **PROCEDURE:** Percutaneous coronary angioplasty/intervention (PCI)
- **DRUG:** Anti-ischemic drug therapy

## Key facts

- **NCT ID:** NCT00387231
- **Lead sponsor:** Luzerner Kantonsspital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1991-06
- **Primary completion:** —
- **Final completion:** 2006-05
- **Target enrollment:** — (—)
- **Last updated:** 2006-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00387231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00387231, "Comparison of Anti-Ischemic Drug Therapy and Percutaneous Transluminal Angioplasty After Myocardial Infarction". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00387231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*